KURE ETF
KraneShares MSCI All China Health Care Index ETF
KURE ETF Overview
KURE ETF (KraneShares MSCI All China Health Care Index ETF) is managed by KraneShares with $110.6M in net assets. KURE expense ratio is 0.65%, holding 50 positions across sectors including Health Care. Inception date: 2018-01-31.
KURE performance shows a YTD return of 7.93%. The 1-year return is -4.76% and the 5-year return is -8.88%. KURE dividend yield stands at 3.86%, paid annually.
KURE top holdings include Innovent Biologics Inc (9.0%), Beigene Ag (8.8%), Wuxi Biologics (cayman) Inc. (7.5%), Wuxi Apptec Co. Ltd. Class A (5.8%), Shenzhen Mindray Bio-Medical Electronic (4.6%). Go to all KURE holdings, KURE sectors, or KURE dividends.
KURE can be compared against other funds. Use KURE overlap to find shared positions, or KURE vs another fund for a side-by-side view. KURE alternatives are available via the screener, along with tax-loss harvesting opportunities.